Current Appointments & Affiliations
Assistant Professor of Medicine
·
2021 - Present
Medicine, Hematology,
Medicine
Recent Publications
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
Journal Article J Oncol Pharm Pract · April 2019 BACKGROUND: Immune checkpoint inhibitors are poised to revolutionize the management of a growing number of malignancies. Unfortunately, the management of steroid-refractory immune mediated adverse events is based on a paucity of randomized data and limited ... Full text Link to item CiteUnusual disease characteristics of multiple myeloma in eastern North Carolina.
Conference Journal of Clinical Oncology · May 20, 2017 e19512 Background:Multiple Myeloma (MM) is a relatively common malignancy in Eastern NC, especially in African American population. There have been several advances in treatment of MM but it is unclear how well current therapies ... Full text CiteSystemic inflammatory response syndrome (SIRS) with immune checkpoint inhibitors.
Conference Journal of Clinical Oncology · May 20, 2016 Full text CiteEducation, Training & Certifications
Gandhi Medical College and Hospital (India) ·
2002
M.B.B.S.